Could cause temporary or reversible harm; serious harm is unlikely.
Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.
| Distributed by / for | Franck's Lab Inc., d.b.a. Franck's Compounding Lab |
| Full product label | POTASSIUM CHLORIDE ***(30ML VIAL) 2MEQ/ML INJECTABLE 750 MLS; POTASSIUM CHLORIDE IN NORMAL SALINE 40MEQ/100ML (400MEQ/L) INJECTABLE 1000 ML; POTASSIUM CHLORIDE**(25X20ML) 2MEQ/ML INJECTABLE 500 ML; POTASSIUM PHOSPHATE 4.4MEQ/ML (3MMOL/ML) INJECTABLE 300 ML 750 ML (5 DIFFERENT PRODUCTS) |
| Recalling firm | Franck's Lab Inc., d.b.a. Franck's Compounding Lab |
| Distribution | Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies |
| Quantity | 6 units |
| Recall initiated | 2012-05-21 |
| Report date | 2012-08-22 |
| Recall completed | 2014-08-15 |
| Recall number | D-1603-2012 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Ocala FL United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗